celecoxib has been researched along with Dysphagia in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celecoxib 400 mg was taken orally twice daily during chemoradiation, up to 1 week before surgery, and for 6 months following surgery." | 2.82 | Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer. ( Bueno, R; Choi, N; Cleary, JM; Donahue, DM; Enzinger, PC; Fidias, PM; Fuchs, CS; Gaissert, HA; Jaklitsch, MT; Kulke, MH; Lynch, TP; Mamon, HJ; Mentzer, SJ; Meyerhardt, JA; Swanson, RS; Szymonifka, J; Wain, J, 2016) |
| "Celecoxib treatment (100 mg/day) was initiated for local pain management." | 1.51 | Celecoxib as a Potential Treatment for Intractable Lymphatic Malformation. ( Imamura, M; Kawamura, J; Kawano, Y; Nishikawa, T; Okamoto, Y; Yamasaki, Y; Yoneyama, T, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imamura, M | 1 |
| Okamoto, Y | 1 |
| Nishikawa, T | 1 |
| Yoneyama, T | 1 |
| Yamasaki, Y | 1 |
| Kawamura, J | 1 |
| Kawano, Y | 1 |
| Cleary, JM | 1 |
| Mamon, HJ | 1 |
| Szymonifka, J | 1 |
| Bueno, R | 1 |
| Choi, N | 1 |
| Donahue, DM | 1 |
| Fidias, PM | 1 |
| Gaissert, HA | 1 |
| Jaklitsch, MT | 1 |
| Kulke, MH | 1 |
| Lynch, TP | 1 |
| Mentzer, SJ | 1 |
| Meyerhardt, JA | 1 |
| Swanson, RS | 1 |
| Wain, J | 1 |
| Fuchs, CS | 1 |
| Enzinger, PC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Trial of Cisplatin, CPT-11, Celecoxib (PCC), Concurrent Radiation Therapy, and Surgery for Resectable Esophageal Cancer[NCT00137852] | Phase 2 | 35 participants (Actual) | Interventional | 2002-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for celecoxib and Dysphagia
| Article | Year |
|---|---|
Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer.
Topics: Administration, Oral; Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Camptot | 2016 |
1 other study available for celecoxib and Dysphagia
| Article | Year |
|---|---|
Celecoxib as a Potential Treatment for Intractable Lymphatic Malformation.
Topics: Airway Obstruction; Celecoxib; Child; Cyclooxygenase 2 Inhibitors; Deglutition Disorders; Female; Hu | 2019 |